8 female age at least 8 year or of child-bearing potential must have a negative serum beta-hcg at visit 1 and a negative urine pregnancy test prior to titration at visit 2 female participant of childbearing potential must agree for the duration of the study and for a period of at least 60 day follow administration of the last dose of study drug to be abstinent or commit to the consistent and correct use of a medically acceptable method of birth control e.g. a double-barrier method condom spermicide condom diaphragm with spermicide 